What one share of Organogenesis Holdings holds
Organogenesis is a leading regenerative medicine company focused on empowering healing through the development, manufacturing, and sale of products for the advanced wound care and surgical and sports medicine markets.
Organogenesis Holdings’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $3.49 |
|---|---|
| Profit | −$0.78 |
| Capex (buildings and equipment) | $0.08 |
| Free cash flow | $0.16 |
| Cash and investments | $0.36 |
| Book value | $1.15 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $2.20 | −$0.27 | $0.02 | −$0.10 | — | −$0.25 |
| 2017 | $3.11 | −$0.14 | $0.04 | −$0.09 | — | −$0.23 |
| 2018 | $2.79 | −$0.94 | $0.03 | −$0.90 | — | $0.44 |
| 2019 | $2.81 | −$0.42 | $0.06 | −$0.43 | — | $0.50 |
| 2020 | $3.04 | $0.15 | $0.16 | −$0.11 | — | $1.11 |
| 2021 | $3.50 | $0.70 | $0.23 | $0.23 | — | $1.88 |
| 2022 | $3.41 | $0.12 | $0.26 | −$0.07 | — | $2.03 |
| 2023 | $3.26 | $0.04 | $0.18 | $0.05 | — | $2.12 |
| 2024 | $3.66 | −$0.01 | $0.08 | $0.03 | — | $2.09 |
| 2025 | $4.33 | $0.15 | $0.11 | −$0.19 | — | $2.36 |
Common questions about Organogenesis Holdings
How much does one share of Organogenesis Holdings earn?
Over the last 12 months, Organogenesis Holdings lost $0.78 for each share on $3.49 of sales.
Does Organogenesis Holdings pay a dividend?
Organogenesis Holdings didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Organogenesis Holdings’s book value per share?
Organogenesis Holdings’s book value is $1.15 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Organogenesis Holdings have?
Each share of Organogenesis Holdings has $0.36 of cash and investments, as of June 30, 2026.
What is Organogenesis Holdings’s free cash flow per share?
$0.16 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Organogenesis Holdings bought back shares?
Organogenesis Holdings’s share count rose about 106% from 2016 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.